Swiss Re


Good start in FY2021 despite COVID-19 claims

30/04/21 -"• Net premiums earned rose by 7% to $10.2bn • Impact of the COVID-19 crisis on the underwriting result of the group was $643m for Q1 21. • Net result was a profit of $333m for Q1 21 compared to a ..."

Pages
55
Language
English
Published on
30/04/21
You may also be interested by these reports :
06/05/21
• Net premiums earned increased by 1% to €12.8bn in Q1 21 • COVID-19 claims were around €290m for Q1 21 compared to around €800m for Q1 20 • Pre-tax ...

06/05/21
• Net profit attributable to shareholders increased by 25% to €277m for Q1 21 • Large loss expenses from the COVID-19 pandemic of €157m in Q1 21 were ...

06/05/21
Sampo’s Q1 results has surprised the insurance world, beating expectations. However, although the insurer has reported a great performance, this ...

05/05/21
Axa’s Q1 2021 results and earnings’ call confirm our previous comments: 2021 is about restructuring towards its core markets while recovering from ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO